National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

50% oxygen/50% nitrous oxide premix
An equimolar gas mixture of oxygen (O2) and nitrous oxide (N2O) with potential analgesic activity. Upon inhalation, 50% oxygen/50% nitrous oxide premix produces rapidly reversible analgesia. The exact mechanism through which nitrous oxide exerts its analgesic effect has yet to be fully elucidated, but it it appears to be associated with the neuronal release of endogenous opioid peptides. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Foreign brand name:Kalinox 170 bar



Previous:4-hydroxytamoxifen, 4-nitroestrone 3-methyl ether, 5,10-methylenetetrahydrofolate, 5-[18F]fluorouracil, 5-hydroxytryptophan
Next:6-azauridine, 7-cyanoquinocarcinol, 7-hydroxystaurosporine, 8-hydroxyquinoline sulfate ointment, 851B gel

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov